nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—Application site burn—Fluorouracil—head and neck cancer	0.0492	0.0492	CcSEcCtD
Clindamycin—Superinfection—Fluorouracil—head and neck cancer	0.0455	0.0455	CcSEcCtD
Clindamycin—Diarrhoea haemorrhagic—Docetaxel—head and neck cancer	0.0295	0.0295	CcSEcCtD
Clindamycin—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.0244	0.0244	CcSEcCtD
Clindamycin—Skin irritation—Fluorouracil—head and neck cancer	0.0239	0.0239	CcSEcCtD
Clindamycin—Application site pain—Fluorouracil—head and neck cancer	0.0235	0.0235	CcSEcCtD
Clindamycin—Application site reaction—Fluorouracil—head and neck cancer	0.022	0.022	CcSEcCtD
Clindamycin—Digestion impaired—Hydroxyurea—head and neck cancer	0.0214	0.0214	CcSEcCtD
Clindamycin—Oesophageal ulcer—Docetaxel—head and neck cancer	0.0204	0.0204	CcSEcCtD
Clindamycin—Local reaction—Fluorouracil—head and neck cancer	0.0186	0.0186	CcSEcCtD
Clindamycin—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.0175	0.0175	CcSEcCtD
Clindamycin—Tenderness—Hydroxyurea—head and neck cancer	0.0164	0.0164	CcSEcCtD
Clindamycin—Prurigo—Docetaxel—head and neck cancer	0.0161	0.0161	CcSEcCtD
Clindamycin—Ulcer—Hydroxyurea—head and neck cancer	0.0152	0.0152	CcSEcCtD
Clindamycin—Skin exfoliation—Hydroxyurea—head and neck cancer	0.0137	0.0137	CcSEcCtD
Clindamycin—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.013	0.013	CcSEcCtD
Clindamycin—Stinging—Fluorouracil—head and neck cancer	0.0127	0.0127	CcSEcCtD
Clindamycin—Tenderness—Fluorouracil—head and neck cancer	0.0118	0.0118	CcSEcCtD
Clindamycin—Redness—Docetaxel—head and neck cancer	0.011	0.011	CcSEcCtD
Clindamycin—Leukocytosis—Fluorouracil—head and neck cancer	0.011	0.011	CcSEcCtD
Clindamycin—Ulcer—Fluorouracil—head and neck cancer	0.0109	0.0109	CcSEcCtD
Clindamycin—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.0109	0.0109	CcSEcCtD
Clindamycin—Inflammation—Fluorouracil—head and neck cancer	0.0106	0.0106	CcSEcCtD
Clindamycin—Dermatitis contact—Fluorouracil—head and neck cancer	0.0102	0.0102	CcSEcCtD
Clindamycin—Rash erythematous—Docetaxel—head and neck cancer	0.00973	0.00973	CcSEcCtD
Clindamycin—Oesophagitis—Fluorouracil—head and neck cancer	0.00943	0.00943	CcSEcCtD
Clindamycin—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00938	0.00938	CcSEcCtD
Clindamycin—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00865	0.00865	CcSEcCtD
Clindamycin—Swelling—Fluorouracil—head and neck cancer	0.00849	0.00849	CcSEcCtD
Clindamycin—Dysuria—Hydroxyurea—head and neck cancer	0.00841	0.00841	CcSEcCtD
Clindamycin—Neutropenia—Hydroxyurea—head and neck cancer	0.00841	0.00841	CcSEcCtD
Clindamycin—Agranulocytosis—Vinblastine—head and neck cancer	0.00821	0.00821	CcSEcCtD
Clindamycin—Oliguria—Docetaxel—head and neck cancer	0.00808	0.00808	CcSEcCtD
Clindamycin—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00784	0.00784	CcSEcCtD
Clindamycin—Inflammation—Docetaxel—head and neck cancer	0.00768	0.00768	CcSEcCtD
Clindamycin—Colitis—Docetaxel—head and neck cancer	0.00715	0.00715	CcSEcCtD
Clindamycin—Cardiac arrest—Fluorouracil—head and neck cancer	0.00712	0.00712	CcSEcCtD
Clindamycin—Skin exfoliation—Docetaxel—head and neck cancer	0.00711	0.00711	CcSEcCtD
Clindamycin—Candida infection—Docetaxel—head and neck cancer	0.00711	0.00711	CcSEcCtD
Clindamycin—Dry skin—Fluorouracil—head and neck cancer	0.00687	0.00687	CcSEcCtD
Clindamycin—Oesophagitis—Docetaxel—head and neck cancer	0.00681	0.00681	CcSEcCtD
Clindamycin—Eosinophilia—Fluorouracil—head and neck cancer	0.00641	0.00641	CcSEcCtD
Clindamycin—Anaemia—Vinblastine—head and neck cancer	0.00635	0.00635	CcSEcCtD
Clindamycin—Erythema—Hydroxyurea—head and neck cancer	0.00627	0.00627	CcSEcCtD
Clindamycin—Thrombophlebitis—Docetaxel—head and neck cancer	0.00625	0.00625	CcSEcCtD
Clindamycin—Vertigo—Vinblastine—head and neck cancer	0.00617	0.00617	CcSEcCtD
Clindamycin—Leukopenia—Vinblastine—head and neck cancer	0.00615	0.00615	CcSEcCtD
Clindamycin—Swelling—Docetaxel—head and neck cancer	0.00613	0.00613	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00602	0.00602	CcSEcCtD
Clindamycin—Hypertension—Vinblastine—head and neck cancer	0.00593	0.00593	CcSEcCtD
Clindamycin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00591	0.00591	CcSEcCtD
Clindamycin—Anaemia—Hydroxyurea—head and neck cancer	0.00579	0.00579	CcSEcCtD
Clindamycin—Discomfort—Vinblastine—head and neck cancer	0.00578	0.00578	CcSEcCtD
Clindamycin—Dermatitis bullous—Docetaxel—head and neck cancer	0.00566	0.00566	CcSEcCtD
Clindamycin—Urinary tract infection—Fluorouracil—head and neck cancer	0.00561	0.00561	CcSEcCtD
Clindamycin—Leukopenia—Hydroxyurea—head and neck cancer	0.00561	0.00561	CcSEcCtD
Clindamycin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00549	0.00549	CcSEcCtD
Clindamycin—Epistaxis—Fluorouracil—head and neck cancer	0.00544	0.00544	CcSEcCtD
Clindamycin—Agranulocytosis—Fluorouracil—head and neck cancer	0.00539	0.00539	CcSEcCtD
Clindamycin—Discomfort—Hydroxyurea—head and neck cancer	0.00527	0.00527	CcSEcCtD
Clindamycin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00501	0.00501	CcSEcCtD
Clindamycin—Dry skin—Docetaxel—head and neck cancer	0.00496	0.00496	CcSEcCtD
Clindamycin—Abdominal pain upper—Docetaxel—head and neck cancer	0.00494	0.00494	CcSEcCtD
Clindamycin—Cramp muscle—Docetaxel—head and neck cancer	0.00487	0.00487	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00487	0.00487	CcSEcCtD
Clindamycin—Pain—Vinblastine—head and neck cancer	0.0048	0.0048	CcSEcCtD
Clindamycin—Constipation—Vinblastine—head and neck cancer	0.0048	0.0048	CcSEcCtD
Clindamycin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00459	0.00459	CcSEcCtD
Clindamycin—Dyspnoea—Hydroxyurea—head and neck cancer	0.00456	0.00456	CcSEcCtD
Clindamycin—Erythema—Fluorouracil—head and neck cancer	0.00451	0.00451	CcSEcCtD
Clindamycin—Dyspepsia—Hydroxyurea—head and neck cancer	0.0045	0.0045	CcSEcCtD
Clindamycin—Abdominal pain—Vinblastine—head and neck cancer	0.00443	0.00443	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00442	0.00442	CcSEcCtD
Clindamycin—Fatigue—Hydroxyurea—head and neck cancer	0.00441	0.00441	CcSEcCtD
Clindamycin—Constipation—Hydroxyurea—head and neck cancer	0.00437	0.00437	CcSEcCtD
Clindamycin—Pain—Hydroxyurea—head and neck cancer	0.00437	0.00437	CcSEcCtD
Clindamycin—Neutropenia—Docetaxel—head and neck cancer	0.00437	0.00437	CcSEcCtD
Clindamycin—Anaemia—Fluorouracil—head and neck cancer	0.00417	0.00417	CcSEcCtD
Clindamycin—Hypersensitivity—Vinblastine—head and neck cancer	0.00413	0.00413	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00413	0.00413	CcSEcCtD
Clindamycin—Jaundice—Docetaxel—head and neck cancer	0.00406	0.00406	CcSEcCtD
Clindamycin—Body temperature increased—Hydroxyurea—head and neck cancer	0.00404	0.00404	CcSEcCtD
Clindamycin—Leukopenia—Fluorouracil—head and neck cancer	0.00404	0.00404	CcSEcCtD
Clindamycin—Asthenia—Vinblastine—head and neck cancer	0.00402	0.00402	CcSEcCtD
Clindamycin—Epistaxis—Docetaxel—head and neck cancer	0.00393	0.00393	CcSEcCtD
Clindamycin—Agranulocytosis—Docetaxel—head and neck cancer	0.00389	0.00389	CcSEcCtD
Clindamycin—Diarrhoea—Vinblastine—head and neck cancer	0.00384	0.00384	CcSEcCtD
Clindamycin—Discomfort—Fluorouracil—head and neck cancer	0.00379	0.00379	CcSEcCtD
Clindamycin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00377	0.00377	CcSEcCtD
Clindamycin—Dizziness—Vinblastine—head and neck cancer	0.00371	0.00371	CcSEcCtD
Clindamycin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00368	0.00368	CcSEcCtD
Clindamycin—Asthenia—Hydroxyurea—head and neck cancer	0.00367	0.00367	CcSEcCtD
Clindamycin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.0036	0.0036	CcSEcCtD
Clindamycin—Vomiting—Vinblastine—head and neck cancer	0.00357	0.00357	CcSEcCtD
Clindamycin—Erythema multiforme—Docetaxel—head and neck cancer	0.00354	0.00354	CcSEcCtD
Clindamycin—Headache—Vinblastine—head and neck cancer	0.00351	0.00351	CcSEcCtD
Clindamycin—Diarrhoea—Hydroxyurea—head and neck cancer	0.0035	0.0035	CcSEcCtD
Clindamycin—Flushing—Docetaxel—head and neck cancer	0.00347	0.00347	CcSEcCtD
Clindamycin—Hypotension—Fluorouracil—head and neck cancer	0.00344	0.00344	CcSEcCtD
Clindamycin—Dizziness—Hydroxyurea—head and neck cancer	0.00338	0.00338	CcSEcCtD
Clindamycin—Nausea—Vinblastine—head and neck cancer	0.00333	0.00333	CcSEcCtD
Clindamycin—Dyspnoea—Fluorouracil—head and neck cancer	0.00328	0.00328	CcSEcCtD
Clindamycin—Erythema—Docetaxel—head and neck cancer	0.00326	0.00326	CcSEcCtD
Clindamycin—Vomiting—Hydroxyurea—head and neck cancer	0.00325	0.00325	CcSEcCtD
Clindamycin—Dyspepsia—Fluorouracil—head and neck cancer	0.00324	0.00324	CcSEcCtD
Clindamycin—Rash—Hydroxyurea—head and neck cancer	0.00322	0.00322	CcSEcCtD
Clindamycin—Dermatitis—Hydroxyurea—head and neck cancer	0.00322	0.00322	CcSEcCtD
Clindamycin—Headache—Hydroxyurea—head and neck cancer	0.0032	0.0032	CcSEcCtD
Clindamycin—Dysgeusia—Docetaxel—head and neck cancer	0.00319	0.00319	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00318	0.00318	CcSEcCtD
Clindamycin—Back pain—Docetaxel—head and neck cancer	0.00315	0.00315	CcSEcCtD
Clindamycin—Pain—Fluorouracil—head and neck cancer	0.00315	0.00315	CcSEcCtD
Clindamycin—Muscle spasms—Docetaxel—head and neck cancer	0.00313	0.00313	CcSEcCtD
Clindamycin—Nausea—Hydroxyurea—head and neck cancer	0.00304	0.00304	CcSEcCtD
Clindamycin—Anaemia—Docetaxel—head and neck cancer	0.00301	0.00301	CcSEcCtD
Clindamycin—Urticaria—Fluorouracil—head and neck cancer	0.00292	0.00292	CcSEcCtD
Clindamycin—Leukopenia—Docetaxel—head and neck cancer	0.00291	0.00291	CcSEcCtD
Clindamycin—Body temperature increased—Fluorouracil—head and neck cancer	0.00291	0.00291	CcSEcCtD
Clindamycin—Hypertension—Docetaxel—head and neck cancer	0.00281	0.00281	CcSEcCtD
Clindamycin—Hypersensitivity—Fluorouracil—head and neck cancer	0.00271	0.00271	CcSEcCtD
Clindamycin—Anaphylactic shock—Docetaxel—head and neck cancer	0.00266	0.00266	CcSEcCtD
Clindamycin—Pruritus—Fluorouracil—head and neck cancer	0.0026	0.0026	CcSEcCtD
Clindamycin—Thrombocytopenia—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Clindamycin—Diarrhoea—Fluorouracil—head and neck cancer	0.00252	0.00252	CcSEcCtD
Clindamycin—Hypotension—Docetaxel—head and neck cancer	0.00248	0.00248	CcSEcCtD
Clindamycin—Dizziness—Fluorouracil—head and neck cancer	0.00243	0.00243	CcSEcCtD
Clindamycin—Dyspnoea—Docetaxel—head and neck cancer	0.00237	0.00237	CcSEcCtD
Clindamycin—Vomiting—Fluorouracil—head and neck cancer	0.00234	0.00234	CcSEcCtD
Clindamycin—Dyspepsia—Docetaxel—head and neck cancer	0.00234	0.00234	CcSEcCtD
Clindamycin—Rash—Fluorouracil—head and neck cancer	0.00232	0.00232	CcSEcCtD
Clindamycin—Dermatitis—Fluorouracil—head and neck cancer	0.00232	0.00232	CcSEcCtD
Clindamycin—Headache—Fluorouracil—head and neck cancer	0.00231	0.00231	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00229	0.00229	CcSEcCtD
Clindamycin—Fatigue—Docetaxel—head and neck cancer	0.00229	0.00229	CcSEcCtD
Clindamycin—Pain—Docetaxel—head and neck cancer	0.00227	0.00227	CcSEcCtD
Clindamycin—Constipation—Docetaxel—head and neck cancer	0.00227	0.00227	CcSEcCtD
Clindamycin—Nausea—Fluorouracil—head and neck cancer	0.00219	0.00219	CcSEcCtD
Clindamycin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00217	0.00217	CcSEcCtD
Clindamycin—Body temperature increased—Docetaxel—head and neck cancer	0.0021	0.0021	CcSEcCtD
Clindamycin—Abdominal pain—Docetaxel—head and neck cancer	0.0021	0.0021	CcSEcCtD
Clindamycin—Hypersensitivity—Docetaxel—head and neck cancer	0.00196	0.00196	CcSEcCtD
Clindamycin—Asthenia—Docetaxel—head and neck cancer	0.00191	0.00191	CcSEcCtD
Clindamycin—Pruritus—Docetaxel—head and neck cancer	0.00188	0.00188	CcSEcCtD
Clindamycin—Diarrhoea—Docetaxel—head and neck cancer	0.00182	0.00182	CcSEcCtD
Clindamycin—Dizziness—Docetaxel—head and neck cancer	0.00176	0.00176	CcSEcCtD
Clindamycin—Vomiting—Docetaxel—head and neck cancer	0.00169	0.00169	CcSEcCtD
Clindamycin—Rash—Docetaxel—head and neck cancer	0.00168	0.00168	CcSEcCtD
Clindamycin—Dermatitis—Docetaxel—head and neck cancer	0.00167	0.00167	CcSEcCtD
Clindamycin—Headache—Docetaxel—head and neck cancer	0.00166	0.00166	CcSEcCtD
Clindamycin—Nausea—Docetaxel—head and neck cancer	0.00158	0.00158	CcSEcCtD
